🚀 VC round data is live in beta, check it out!
PEPTONIC medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for PEPTONIC medical and similar public comparables like Adiuvo Investments, Milton Essex, Luxbright, Invent Medic Sweden and more.
PEPTONIC medical Overview
About PEPTONIC medical
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.
Founded
2009
HQ
Employees
2
Website
Sectors
Financials (FY)
EV
$3M
PEPTONIC medical Financials
PEPTONIC medical reported last fiscal year revenue of $2M and negative EBITDA of ($1M).
In the same fiscal year, PEPTONIC medical generated $1M in gross profit, ($1M) in EBITDA losses, and had net loss of ($2M).
PEPTONIC medical P&L
In the most recent fiscal year, PEPTONIC medical reported revenue of $2M and EBITDA of ($1M).
PEPTONIC medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $2M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $1M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 67% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (92%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (132%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (152%) | XXX | XXX | XXX |
| Net Debt | — | — | $1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
PEPTONIC medical Stock Performance
PEPTONIC medical has current market cap of $2M, and enterprise value of $3M.
Market Cap Evolution
PEPTONIC medical's stock price is $0.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3M | $2M | 0.3% | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPEPTONIC medical Valuation Multiples
PEPTONIC medical trades at 2.0x EV/Revenue multiple, and (2.2x) EV/EBITDA.
PEPTONIC medical Financial Valuation Multiples
As of April 19, 2026, PEPTONIC medical has market cap of $2M and EV of $3M.
Equity research analysts estimate PEPTONIC medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
PEPTONIC medical has a P/E ratio of (0.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $3M | XXX | $3M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (2.2x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (1.5x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.0x | XXX | XXX | XXX |
| P/E | — | XXX | (0.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified PEPTONIC medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
PEPTONIC medical Margins & Growth Rates
PEPTONIC medical's revenue in the last fiscal year declined by (45%).
PEPTONIC medical's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $1.6M for the same period.
PEPTONIC medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (45%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (92%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (74%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.6M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 199% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
PEPTONIC medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| PEPTONIC medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Adiuvo Investments | XXX | XXX | XXX | XXX | XXX | XXX |
| Milton Essex | XXX | XXX | XXX | XXX | XXX | XXX |
| Luxbright | XXX | XXX | XXX | XXX | XXX | XXX |
| Invent Medic Sweden | XXX | XXX | XXX | XXX | XXX | XXX |
| VibroSense Dynamics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
PEPTONIC medical M&A Activity
PEPTONIC medical acquired XXX companies to date.
Last acquisition by PEPTONIC medical was on XXXXXXXX, XXXXX. PEPTONIC medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by PEPTONIC medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPEPTONIC medical Investment Activity
PEPTONIC medical invested in XXX companies to date.
PEPTONIC medical made its latest investment on XXXXXXXX, XXXXX. PEPTONIC medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by PEPTONIC medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout PEPTONIC medical
| When was PEPTONIC medical founded? | PEPTONIC medical was founded in 2009. |
| Where is PEPTONIC medical headquartered? | PEPTONIC medical is headquartered in Sweden. |
| How many employees does PEPTONIC medical have? | As of today, PEPTONIC medical has over 2 employees. |
| Is PEPTONIC medical publicly listed? | Yes, PEPTONIC medical is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of PEPTONIC medical? | PEPTONIC medical trades under PMED ticker. |
| When did PEPTONIC medical go public? | PEPTONIC medical went public in 2014. |
| Who are competitors of PEPTONIC medical? | PEPTONIC medical main competitors are Adiuvo Investments, Milton Essex, Luxbright, Invent Medic Sweden. |
| What is the current market cap of PEPTONIC medical? | PEPTONIC medical's current market cap is $2M. |
| What is the current revenue of PEPTONIC medical? | PEPTONIC medical's last fiscal year revenue is $2M. |
| What is the current EV/Revenue multiple of PEPTONIC medical? | Current revenue multiple of PEPTONIC medical is 2.0x. |
| Is PEPTONIC medical profitable? | No, PEPTONIC medical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.